Prosecution Insights
Last updated: October 04, 2026
Application No. 17/782,238

CATHETER ASSEMBLY AND RELATED METHODS

Final Rejection §103
Filed
Jun 03, 2022
Priority
Dec 05, 2019 — provisional 62/944,109 +2 more
Examiner
ALEMAN, SARAH WEBB
Art Unit
3774
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Aortic Solutions Inc.
OA Round
2 (Final)
62%
Grant Probability
Moderate
3-4
OA Rounds
0m
Est. Remaining
86%
With Interview

Examiner Intelligence

Grants 62% of resolved cases
62%
Career Allowance Rate
372 granted / 599 resolved
-7.9% vs TC avg
Strong +24% interview lift
Without
With
+23.7%
Interview Lift
resolved cases with interview
Typical timeline
3y 8m
Avg Prosecution
35 currently pending
Career history
629
Total Applications
across all art units

Statute-Specific Performance

§101
0.3%
-39.7% vs TC avg
§103
49.9%
+9.9% vs TC avg
§102
21.3%
-18.7% vs TC avg
§112
19.7%
-20.3% vs TC avg
Black line = Tech Center average estimate • Based on career data from 599 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Response to Arguments Applicant's arguments do not comply with 37 CFR 1.111(c) because they do not clearly point out the patentable novelty which he or she thinks the claims present in view of the state of the art disclosed by the references cited or the objections made. Further, they do not show how the amendments avoid such references or objections. The Examiner’s position regarding obviousness is considered to be clearly stated in the rejections below. Claim Objections Claim 68 is objected to because of the following informalities: the term “engagement assembly” should be amended to correspond with amended claim 64. Appropriate correction is required. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim(s) 38, 40, 43, 46, 47, 56-58, 60-64, and 66-69 are rejected under 35 U.S.C. 103 as being unpatentable over USPAP 2018/0092661 (Prabhu) in view of US 4,222,380 (Terayama). In regard to claim 38: Prabhu discloses an assembly in Fig. 9 comprising an outer shaft (802) with a plurality of engagement members (824) positionable relative to the distal end of the outer shaft, wherein the engagement members move from a collapsed insertion configuration to an expanded shape (Fig. 10A; see description of control of prongs 824 at [0058] and in regard to actuatable elements 315 in Fig. 3A-F at [0040]). Prabhu includes a cutting element (812) carried by and being moveable relative to the elongate body (802) (See description of cutting element moveable relative to catheter at [0036]), which has a shaft and a sharp tip configured to pierce a leaflet of the valve (Fig. 9; [0057-0059]; see description of needle at [0048]). Prabhu discloses the outer shaft defines a first channel having a port defined by its open terminal end (see description of catheter shaft 102 at [0036]), and a cutting mechanism routed through the catheter and out of the port (distal end 106; see Figure 1; [0036]). Prabhu teaches that forming the cutting element to be moveable within the outer shaft is an obvious alternative to form the cutting mechanism to be coupled to the distal end of the catheter [0036][, but fails to explicitly disclose or teach an inner catheter moveable within the first channel that carries the cutting element. Terayama discloses another surgical device having both an engagement assembly with first and second engagement members (41) in combination with a cutting element (needle 42). Terayama includes an outer catheter (16) defining a first channel in which an inner catheter (19) is disposed, wherein the needle (42) is moveable within the second channel defined by the inner catheter from a retracted position of Figure 3 to an extended position of Figure 4. One of ordinary skill in the art before the effective filing date of the claimed invention would have found it obvious to construct the Prabhu device to so that the cutting element is carried on an inner shaft moveable within the outer shaft, as taught by Terayama, as the modification merely involves a combination of known catheters according to known methods that obtains a predictable result of a surgical instrument having relatively moveable tissue engagement and cutting elements. In regard to claim 40, modified Prabhu has a cutting element capable of being moveable from a retracted configuration within the outer shaft (see Fig. 3 of Terayama) to an extended configuration out of the port (see Fig. 4 of Terayama). Regarding claim 43, Prabhu discloses the cutting element can be electrified (either by power source Fig. 4 [0046]; RF energy [0049] or thermal energy [0051]). Regarding claim 46, the cutting element has a first sharpened region defined by the sharp tip (see description of needle structure of cutting element at [0048]). In regard to claim 56, Terayama further teaches that the handle includes a locking element (ball and detent) enabling the cutting element (needle 42) to be locked relative to the elongate body (16) (Fig. 1-3; see description of driving member 32 fixed to proximal end of needle 42; col 4, lines 1-10). One of ordinary skill in the art before the effective filing date of the claimed invention would have found it obvious to include a locking mechanism on the modified Prabhu device, as taught by Terayama, as the modification merely involves a combination of known catheters according to known methods that obtains a predictable result of a selectively locking moveable components of a catheter system. In regard to claim 57, the cutting element (812) is capable of being moved when the engagement members (824) are coupled to the heart valve (see engagement members 41 of Terayama coupled to tissue and needle being moved Fig. 3-4). In regard to claim 58 and 64: Prabhu discloses an assembly in Fig. 9 comprising an outer shaft (802) with a plurality of engagement members (824) positionable relative to the distal end of the outer shaft, wherein the engagement members move from a collapsed insertion configuration to an expanded shape (Fig. 10A; see description of control of prongs 824 at [0058] and in regard to actuatable elements 315 in Fig. 3A-F at [0040]). Prabhu includes a cutting element (812) carried by and being moveable relative to the elongate body (802) (See description of cutting element moveable relative to catheter at [0036]), which has a shaft and a sharp tip configured to pierce a leaflet of the valve (Fig. 9; [0057-0059]; see description of needle at [0048]). The curved needle (812) is considered to be capable of lacerating a valve, as the term “lacerating” is given its broadest reasonable interpretation to encompass the cutting function disclosed by Prabhu (Fig. 5a-b; abstract; [0048]). Prabhu discloses the outer shaft defines a first channel having a port defined by its open terminal end (see description of catheter shaft 102 at [0036]), and a cutting mechanism routed through the catheter and out of the port (distal end 106; see Figure 1; [0036]). Prabhu teaches that forming the cutting element to be moveable within the outer shaft is an obvious alternative to form the cutting mechanism to be coupled to the distal end of the catheter [0036][, but fails to explicitly disclose or teach an inner catheter moveable within the first channel that carries the cutting element. Terayama discloses another surgical device having both an engagement assembly with first and second engagement members (41) in combination with a cutting element (needle 42). Terayama includes an outer catheter (16) defining a first channel in which an inner catheter (19) is disposed, wherein the needle (42) is moveable within the second channel defined by the inner catheter from a retracted position of Figure 3 to an extended position of Figure 4. One of ordinary skill in the art before the effective filing date of the claimed invention would have found it obvious to construct the Prabhu device to so that the cutting element is carried on an inner shaft moveable within the outer shaft, as taught by Terayama, as the modification merely involves a combination of known catheters according to known methods that obtains a predictable result of a surgical instrument having relatively moveable tissue engagement and cutting elements. In regard to claims 60 and 66, modified Prabhu has a cutting element capable of being moveable from a retracted configuration within the outer shaft (see Fig. 3 of Terayama) to an extended configuration out of the port (see Fig. 4 of Terayama). Regarding claims 61 and 67, Prabhu discloses the cutting element can be electrified (either by power source Fig. 4 [0046]; RF energy [0049] or thermal energy [0051]). In regard to claims 62 and 68, the cutting element (812) is capable of being moved when the engagement members (824) are coupled to the heart valve (see engagement members 41 of Terayama coupled to tissue and needle being moved Fig. 3-4). In regard to claims 63 and 69, Terayama further teaches that the handle includes a locking element (ball and detent) enabling the cutting element (needle 42) to be locked relative to the elongate body (16) (Fig. 1-3; see description of driving member 32 fixed to proximal end of needle 42; col 4, lines 1-10). One of ordinary skill in the art before the effective filing date of the claimed invention would have found it obvious to include a locking mechanism on the modified Prabhu device, as taught by Terayama, as the modification merely involves a combination of known catheters according to known methods that obtains a predictable result of a selectively locking moveable components of a catheter system. Claim(s) 47 is rejected under 35 U.S.C. 103 as being unpatentable over Prabhu in view of USPAP 2006/0095055 (Douglas et al.). Prabhu discloses the cutting element (812) has a generally curved shape, but fails the cutting element has a sharpened region at the intersection of a shaft and an angled leg. Douglas discloses another cutting device with a blade configured for cutting blood vessels. As shown in Figure 5a-c, the blade comprises a piercing tip (148d/248d/348d), an angled leg (148b,248b,348b), a shaft (147, 247 and 347, and a sharpened region (148a, 248a, and 348a) at the intersection of the shaft and the angled leg. Since the Douglas device is in the same field of endeavor of cutting vasculature (abstract), one of ordinary skill in the art would have found it obvious to modify the cutting element of Prabhu to include a sharpened region at the intersection of a shaft and an angled leg, as taught by Douglas, as the modification merely involves a combination of known surgical cutting blades according to known methods that obtains a predictable result. Conclusion Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to SARAH WEBB ALEMAN whose telephone number is (571)272-5749. The examiner can normally be reached M, Tu, Th, Fr 9am - 3pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Melanie Tyson can be reached at 571-272-9062. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /SARAH W ALEMAN/Primary Examiner, Art Unit 3774
Read full office action

Prosecution Timeline

Jun 03, 2022
Application Filed
Nov 07, 2025
Non-Final Rejection (signed) — §103
Jan 20, 2026
Non-Final Rejection mailed — §103
Jul 20, 2026
Response Filed
Sep 24, 2026
Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12740880
DEVICES AND METHODS FOR TREATING BRANCHING BLOOD VESSELS
4y 0m to grant Granted Sep 22, 2026
Patent 12734056
MEDICAL TUBULAR BODY DELIVERING DEVICE
4y 3m to grant Granted Sep 15, 2026
Patent 12714586
BIFURCATED BALLOON EXPANDABLE STENT ASSEMBLY
4y 1m to grant Granted Aug 25, 2026
Patent 12714291
CHANNEL REPLACEMENT METHOD, ENDOSCOPE, AND PLUG
3y 0m to grant Granted Aug 25, 2026
Patent 12708399
TRANSCATHETER VALVE LACERATION DEVICE AND METHOD
4y 1m to grant Granted Aug 18, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
62%
Grant Probability
86%
With Interview (+23.7%)
3y 8m (~0m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 599 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month